Abstract

Measurement of Free Iodine in Different Formulations of Povidone-Iodine Eye Drops 5%

Author(s): Berisa Prado Silvia, Riestra Ayora Ana Cristina, Trelles Campa Adrián

Issue: Sep/Oct 2019 - Volume 23, Number 5

Page(s): 418-421

Download in electronic PDF format for $75
  • Measurement of Free Iodine in Different Formulations of Povidone-Iodine Eye Drops 5% Page 1
  • Measurement of Free Iodine in Different Formulations of Povidone-Iodine Eye Drops 5% Page 2
  • Measurement of Free Iodine in Different Formulations of Povidone-Iodine Eye Drops 5% Page 3
  • Measurement of Free Iodine in Different Formulations of Povidone-Iodine Eye Drops 5% Page 4

Abstract

There are multiple studies in the literature that support the use of povidone iodine in the preparation of the surgical field of cataract as the most effective means to reduce the bacteria present in the ocular surface and the risk of infection. The concentration of free iodine is related to the antiseptic activity of these compounds, being, therefore, a good indicator of its effectiveness. The objective of this study was to determine the amount of free iodine and the evolution of it in different formulations of povidone iodine eye drops. The povidone iodine 5% eye drops were prepared starting from Betadine 10% dermal or the active principle and using a solvent, phosphate-citrate buffer solution, and sodium chloride 0.9% or sterile water for injection. Aliquots of 5 mL were packed in low-absorption absorption eye drops, topaz glass vials, and polyethylene syringe. The determination of free iodine was made by volumetric titration. Titration was performed with 0.1 M sodium thiosulfate using a starch solution as an indicator. Of the 0.1 M sodium thiosulfate, 1 mL is equivalent to 12.69 mg of available iodine, and it is expressed as a percentage of free iodine in the iodized povidone (% free iodine). Eyewash titrations were performed by replacing the substance with 5 mL of eye drops and following the remaining steps. Valuations were made on days 0, 7, and 14, as well as the measurement of pH and osmolarity. The results show that there are no differences between the average results at the three measurements taken on days 0, 7, and 14. We conclude that the free iodine remains stable during the stability period of 14 days. Regarding the pH and osmolarity data, the authors believe that the best tolerated formula will be that elaborated with povidone iodine and a phosphate- citrate buffer solution.

Related Keywords

  • povidone-iodine eye drops
  • ophthalmologic surgery
  • complications
  • postoperative endophthalmitis
  • visual acuity
  • retinal detachment
  • eye injury
  • surgical field preparation
  • cataract surgery
  • ocular surface microbes
  • antiseptic agent
  • prophylaxis
  • solvents
  • free iodine
  • osmolarity
  • physical stability
  • chemical stability
  • storage containers
  • phosphate-citrate buffer solution

Related Categories

  • OPHTHALMICS
  • PEER-REVIEWED
  • INFECTIOUS DISEASE

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Sep/Oct 2019
Pg. 418-421
Measurement of Free Iodine in Different Formulations of Povidone-Iodine Eye Drops 5%
Author(s): Berisa Prado Silvia, Riestra Ayora Ana Cristina, Trelles Campa Adrián
Nov/Dec 2009
Pg. 506-515
Autologous Eye Drops for the Treatment of Dry Eye and Neurotrophic Keratitis
Author(s): Mixon William, Angelle Patricea (Patsy), Chang Richard I
Sep/Oct 2014
Pg. 418-426
Stability and In Vitro Toxicity of an Infliximab Eye Drop Formulation
Author(s): Robert Marie-Claude, Spurr-Michaud Sandra, Frenette Mathieu, Young David, Gipson Ilene K, Dohlman Claes H
Nov/Dec 2009
Pg. 540-543
Quality-Control Analytical Methods: Applications and Sterility of Autologous Eye Drops
Author(s): Reed-Kane Dana, Carlson Rachel A, Kupiec Thomas C, Vu Nicole
Jul/Aug 2022
Pg. 328
Povidone Iodine 100-mg/mL Solution/Spray
Author(s): Allen Loyd V Jr
Sep/Oct 2023
Pg. 421
Povidone Iodine Lotion
Author(s): Allen Loyd V Jr
Sep/Oct 2015
Pg. 409
Povidone Iodine 10% Cold Sore Paint
Author(s): Allen Loyd V Jr
Jan/Feb 2023
Pg. 56
Povidone Iodine 100-mg/mL Solution/Spray
Author(s): Allen Loyd V Jr
Jul/Aug 2022
Pg. 336-341
Long-term Stability of Epitheliotropic Factors in Frozen Serum Eye Drops
Author(s): Sahyoun Jean-Yves, Cloutier Marc, Frenette Mathieu, Robert Marie-Claude
Jul/Aug 2017
Pg. 282-289
Simple Preparation of Timolol 0.5% Gel from Eye Drop Solution for Superficial Infantile Hemangiomas
Author(s): Choo Winnie
May/Jun 2015
Pg. 252-260
Protocol of Blood Serum Eye Drops
Author(s): Katsakoulas Ioannis, Lougovoi Claudia, Paraskevopoulou Penelope, Vougioukas Nikolaos
Sep/Oct 2014
Pg. 370-377
Autologous Serum Eye Drops for Severe Dry Eye Syndrome in a Patient with Chronic Graft-vs-Host Disease: A Case Report
Author(s): Mixon Bill, Mixon Jan, Isbey Edward K III, Sprinkle Shari
May/Jun 2017
Pg. 237
PVP Iodine 10% Antiseptic Cream
Author(s): Allen Loyd V Jr
Jul/Aug 2017
Pg. 319
Tacrolimus 0.06% Ophthalmic Drops
Author(s): Allen Loyd V Jr
Jul/Aug 1997
Pg. 253
Canine Eye Ulceration Drops
Author(s): Allen Loyd V Jr
Jan/Feb 2010
Pg. 70
Ophthalmic Toning-Lubricating Drops
Author(s): Allen Loyd V Jr
May/Jun 2017
Pg. 215-220
Basics of Compounding: 3D Printing--Pharmacy Applications, Part 2
Author(s): Allen Loyd V Jr
Jul/Aug 2022
Pg. 309-315
Sterile Basics of Compounding: How to Implement a Robust Visual-inspection Program
Author(s): Summers Amy
Jul/Aug 1997
Pg. 222-227
Veterinary Compounding: A Bird's Eye View
Author(s): Jordan Dinah G
Mar/Apr 2001
Pg. 131
Iodine 2% in Oil Injection
Author(s): Allen Loyd V Jr